Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?
- 1 December 1991
- Vol. 68 (11) , 2354-2358
- https://doi.org/10.1002/1097-0142(19911201)68:11<2354::aid-cncr2820681104>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Soft tissue fibrosarcoma. A clinicopathologic study of 132 casesCancer, 1989
- Liposarcoma of the musculoskeletal systemCancer, 1987
- High-grade soft tissue sarcomas of the extremitiesCancer, 1986
- Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomasCancer Chemotherapy and Pharmacology, 1985
- The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 casesCancer, 1984
- Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomasMedical and Pediatric Oncology, 1984
- Cyclophosphamide, Doxorubicin, and Cisplatin Combined in the Treatment of Advanced SarcomasMedical and Pediatric Oncology, 1983
- A Clinical Trial Adriamycin (NSC 123127) in Advanced SarcomasOncology, 1976
- Sarcoma of soft tissue: Clinical and histopathologic parameters and response to treatmentCancer, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958